浏览全部资源
扫码关注微信
1.河北省人民医院药学部,石家庄 050051
2.河北省人民医院口腔科,石家庄 050051
3.河北医科大学第一医院药学部,石家庄 050031
Published:15 October 2024,
Received:19 April 2024,
Revised:06 August 2024,
移动端阅览
连玉菲,邱学佳,杨警囡等.标准化分级药学监护服务在慢性气道疾病住院患者中的多维价值分析 Δ[J].中国药房,2024,35(19):2404-2410.
LIAN Yufei,QIU Xuejia,YANG Jingnan,et al.Multidimensional value analysis of standardized and graded pharmaceutical services in hospitalized patients with chronic airway diseases[J].ZHONGGUO YAOFANG,2024,35(19):2404-2410.
连玉菲,邱学佳,杨警囡等.标准化分级药学监护服务在慢性气道疾病住院患者中的多维价值分析 Δ[J].中国药房,2024,35(19):2404-2410. DOI: 10.6039/j.issn.1001-0408.2024.19.14.
LIAN Yufei,QIU Xuejia,YANG Jingnan,et al.Multidimensional value analysis of standardized and graded pharmaceutical services in hospitalized patients with chronic airway diseases[J].ZHONGGUO YAOFANG,2024,35(19):2404-2410. DOI: 10.6039/j.issn.1001-0408.2024.19.14.
目的
2
为构建慢性气道疾病住院患者科学、合理的药学服务新模式提供参考。
方法
2
选取2023年10月-2024年3月在河北省人民医院呼吸科住院并接受药学监护(PC)服务的慢性阻塞性肺疾病及哮喘急性加重的患者250例,采用随机数字表法将其分成对照组(125例)和观察组(125例)。对照组患者住院期间全程给予一般药学服务,观察组患者住院期间全程给予标准化分级PC服务。比较不同PC服务模式在患者临床价值指标、人文价值指标及质量管理指标间的差异。
结果
2
在临床价值评价指标中,观察组患者的疾病治疗目标达成率、吸入装置正确使用得分、药品不良反应发生率、解决药物相关问题数量均显著优于对照组(
P
<0.05)。在人文价值评价指标中,观察组的患者用药依从性得分、药师干预成功率、患者满意度均显著高于对照组(
P
<0.05)。在质量管理评价指标中,观察组患者的药品费用占比、静脉用药占比、抗菌药物使用率、抗菌药物使用强度均显著优于对照组(
P
<0.05);观察组药事服务例数也多于对照组,但两组间各项药事服务例数占比的差异无统计学意义(
P
>0.05)。
结论
2
标准化分级PC服务可帮助药师识别更需要关注和管理的高危患者,提高药师工作效率,提升患者就医体验,是值得推广的新型药学服务模式。
OBJECTIVE
2
To provide reference for constructing scientific and reasonable pharmaceutical service mode for hospitalized patients with chronic airway diseases.
METHODS
2
From October 2023 to March 2024, 250 patients with chronic obstructive pulmonary disease and acute exacerbation of asthma who were hospitalized in the respiratory department of Hebei General Hospital and received pharmaceutical care (PC) were randomly divided into control group (125 cases) and observation group (125 cases). The control group received general pharmaceutical services throughout their hospitalization, while the observation group received standardized and graded pharmaceutical services throughout their hospitalization. The differences in clinical value indicators, humanistic value indicators, and quality management indicators were compared among different PC service models.
RESULTS
2
Among clinical value evaluation indicators, the observation group had better achievement rate of disease treatment goals, correct use score of inhalation devices, the incidence of adverse drug reactions, and the number of drug-related problems solved than the control group (
P
<0.05). Among the humanistic evaluation indicators, compared with the control group, the observation group had better medication compliance scores, pharmacist intervention success rates, and patient satisfaction scores (
P
<0.05). Among quality management evaluation indicators, the proportion of drug costs, the proportion of intravenous medication, the use rate of antibiotics, the intensity of antibiotic use, and the number of pharmaceutical services in the observation group were significantly better than the control group (
P
<0.05).
CONCLUSIONS
2
Standardized and graded pharmaceutical care services have improved the efficiency of pharmacists and service effectiveness, making it a new pharmaceutical service model worth promoting.
咳喘药学服务药学监护分级监护慢性气道疾病
pharmaceutical caregraded monitoringchronic airway disease
卜一珊,徐彦贵,高仲阳. 临床药师开展药学监护工作的新切入点分析[J]. 中国医院药学杂志,2008,28(9):742-743.
BU Y S,XU Y G,GAO Z Y. Analysis of new entry points for clinical pharmacists to carry out pharmaceutical monitoring[J]. Chin J Hosp Pharm,2008,28(9):742-743.
中国健康促进基金会,中国药学会,中国药师协会. 推进药学服务体系建设和医疗保障协同发展专家共识[J]. 医药导报,2022,41(6):755-761.
China Health Promotion Foundation,China Pharmaceutical Association,China Pharmacists Association. Expert consensus on promoting the construction of pharmaceutical service system and collaborative development of medical security[J]. Her Med,2022,41(6):755-761.
国家卫生健康委,国家中医药管理局.关于加快药学服务高质量发展的意见[J].中华人民共和国国家卫生健康委员会公报,2018(11):16-18.
National Health Commission,State Administration of Traditional Chinese Medicine. Opinions on accelerating the high-quality development of pharmaceutical services[J]. Gaz State Counc People’s Repub China,2018 (11):16-18.
廖敏辉,曾平,杨西晓,等. 药学服务转型与健全医保付费体系的关系探索[J].今日药学,2020,30(10):711-714.
LIAO M H,ZENG P,YANG X X,et al. Exploration on the relationship between the transformation of pharmaceutical care and the improvement of medicare payment system[J]. Pharm Today,2020,30(10):711-714.
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis,management and prevention of chronic obstructive pulmonary disease 2023 report [EB/OL]. [2024-02-19]. https://goldcopd.org/2023-gold- report-2/https://goldcopd.org/2023-gold-report-2/.
VENKATESAN P. 2023 GINA report for asthma[J]. Lancet Respir Med,2023,11(7):589.
江苏省药学会医院药学专业委员会,《江苏省医疗机构呼吸与危重症医学科咳喘药学服务门诊质量管理规范》编写组. 江苏省医疗机构呼吸与危重症医学科咳喘药学服务门诊质量管理规范[J]. 中国医院药学杂志,2023,43(9):943-949.
Jiangsu Pharmaceutical Association Hospital Pharmacy Professional Committee,The Drafting Team of the Quality Management Standards for Cough and Asthma Pharmaceutical Services Outpatient Department of Respiratory and Critical Care Medicine in Medical Institutions in Jiangsu Province. Quality management standards for cough and asthma pharmaceutical services outpatient department of respiratory and critical care medicine in medical institutions in Jiangsu Province[J]. Chin J Hosp Pharm,2023,43(9):943-949.
连玉菲,邱学佳,杨警囡,等. 基于药物治疗管理的慢性阻塞性肺疾病患者咳喘药学门诊服务实践[J]. 中国医院药学杂志,2023,43(5):555-560.
LIAN Y F,QIU X J,YANG J N,et al. Practice of cough and asthma pharmacy outpatient service for patients with chronic obstructive pulmonary disease based on medication therapy management[J]. Chin J Hosp Pharm,2023,43(5):555-560.
中华医学会呼吸病学分会慢性阻塞性肺疾病学组,中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南:2021年修订版[J]. 中华结核和呼吸杂志,2021,44(3):170-205.
Chronic Obstructive Pulmonary Disease Group of the Respiratory Disease Branch of the Chinese Medical Association,Chronic Obstructive Pulmonary Disease Working Committee of the Respiratory Physicians Branch of the Chinese Medical Doctor Association. Diagnosis and treatment guidelines for chronic obstructive pulmonary di- sease:revised in 2021[J]. Chin J Tuberc Respir Dis,2021,44(3):170-205.
王导新,熊伟,王勤,等.《中国支气管哮喘防治指南(2020年版)》评述[J]. 西部医学,2022,34(1):1-4.
WANG D X,XIONG W,WANG Q,et al. Review of Guidelines for Bronchial Asthma Prevention and Management (2020 Edition)[J]. Med J West China,2022,34(1):1-4.
田塬,唐贵菊,王继婷,等. 药学服务发展历程及价值体现[J]. 中国药房,2021,32(23):2924-2929.
TIAN Y,TANG G J,WANG J T,et al. Development process and value manifestation of pharmaceutical care[J]. China Pharm,2021,32(23):2924-2929.
HEPLER C D,STRAND L M. Opportunities and responsibilities in pharmaceutical care[J]. Am J Hosp Pharm,1990,47(3):533-543.
REEDER C E. Overview of pharmacoeconomics and pharmaceutical outcomes evaluations[J]. Am J Health Syst Pharm,1995,52(19 Suppl. 4):S5-S8.
临床药学服务价值评价实践指南:第一版[J].医药导报,2024,43 (3):321-333.
Practice guidelines for evaluating the value of clinical pharmacy services:first edition[J] Med J,2024,43 (3):321-333.
谢扬帆,张虹. 临床药学服务研究进展及发展方向[J]. 中国卫生产业,2019,16(10):188-191,194.
XIE Y F,ZHANG H. Research progress and development direction of clinical pharmaceutical services[J]. China Health Ind,2019,16(10):188-191,194.
周博雅,田月,韩容,等. 中国药学服务门诊开展及收费现状调查与分析[J]. 药品评价,2017,14(2):8-13.
ZHOU B Y,TIAN Y,HAN R,et al. Status quo and analysis of pharmacy outpatient services in China[J]. Drug Eval,2017,14(2):8-13.
侯继秋,张红梅,付秀娟,等. 探讨分级药学监护模式在COPD患者中的实践与效果评价[J]. 实用药物与临床,2019,22(2):182-185.
HOU J Q,ZHANG H M,FU X J,et al. Practice and effect evaluation of grading pharmaceutical care mode for COPD patients[J]. Pract Pharm Clin Remedies,2019,22(2):182-185.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution